Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin as a healer

Kavita Golia

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (33)

  1. Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls. 2022-06-30 · Expand citations
  2. Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study. 2022-06-01 · Expand citations
  3. Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study. 2022-01-01 · Expand citations
  4. Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers. 2021-11-18 · Expand citations
  5. Microdosing psychedelics: Motivations, subjective effects and harm reduction. 2020-01-01 · Expand citations
  6. Psychedelic microdosing benefits and challenges: an empirical codebook. 2019-07-10 · Expand citations
  7. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
  8. More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression. 2018-01-01 · Expand citations
  9. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression 2017-06-19 · Expand citations
  10. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. 2014-01-01 · Expand citations
  11. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. 2012-02-07 · Expand citations
  12. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. 2011-11-01 · Expand citations
  13. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. 2006-08-01 · Expand citations
  14. OpenAlex W1859502711
  15. OpenAlex W1978032191
  16. OpenAlex W2007524903
  17. OpenAlex W2469382216
  18. OpenAlex W2788854095
  19. OpenAlex W2789213216
  20. OpenAlex W2895986834
  21. OpenAlex W2907379922
  22. OpenAlex W2951080359
  23. OpenAlex W2958413903
  24. OpenAlex W2978867848
  25. OpenAlex W2981686921
  26. OpenAlex W3112064661
  27. OpenAlex W3122801192
  28. OpenAlex W3134377893
  29. OpenAlex W3149676623
  30. OpenAlex W3152417644
  31. OpenAlex W4281253144
  32. OpenAlex W574700118
  33. OpenAlex W6639162959

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.